Dopamine Agonists (metabolism) < Dopamine Agonists (pharmacology) < Dopamine Agonists (therapeutic use)

Facettes :

List of bibliographic references indexed by Dopamine Agonists (pharmacology)

Number of relevant bibliographic references: 25.
[0-20] [0 - 20][0 - 25][20-24][20-40]

Ident.	Authors (with country if any)	Title
000429 (2016)	Serdar Durdagi [Turquie] ; Ramin Ekhteiari Salmas [Turquie] ; Matthias Stein [Allemagne] ; Mine Yurtsever [Turquie] ; Philip Seeman	Binding Interactions of Dopamine and Apomorphine in D2High and D2Low States of Human Dopamine D2 Receptor Using Computational and Experimental Techniques.
000748 (2015)	Mariano Serrao [Italie] ; Alberto Ranavolo [Italie] ; Carmela Conte [Italie] ; Chiara Davassi [Italie] ; Silvia Mari [Italie] ; Alfonso Fasano [Canada] ; Giorgia Chini [Italie] ; Gianluca Coppola [Italie] ; Francesco Draicchio [Italie] ; Francesco Pierelli [Italie]	Effect of 24-h continuous rotigotine treatment on stationary and non-stationary locomotion in de novo patients with Parkinson disease in an open-label uncontrolled study.
000752 (2015)	Paolo Solla [Italie] ; Alfonso Fasano [Canada] ; Antonino Cannas [Italie] ; Cesare Salvatore Mulas [Italie] ; Maria Giovanna Marrosu [Italie] ; Anthony E. Lang [Canada] ; Francesco Marrosu [Italie]	Dopamine agonist withdrawal syndrome (DAWS) symptoms in Parkinson's disease patients treated with levodopa-carbidopa intestinal gel infusion.
000938 (2014)	Camila C. Aquino [Brésil] ; Tiago Mestre [Canada] ; Anthony E. Lang [Canada]	Restless genital syndrome in Parkinson disease.
000D99 (2013)	Francesca Antonelli [Canada] ; Ji Hyun Ko [Canada] ; Janis Miyasaki [Canada] ; Anthony E. Lang [Canada] ; Sylvain Houle [Canada] ; Franco Valzania [Italie] ; Nicola J. Ray [Canada] ; Antonio P. Strafella [Canada]	Dopamine-Agonists and Impulsivity in Parkinson’s Disease: Impulsive Choices vs. Impulsive Actions
001680 (2011)	Julia Sacher [Canada, Allemagne] ; Eugenii A. Rabiner [Canada] ; Michael Clark [Canada] ; Pablo Rusjan [Canada] ; Alexandra Soliman [Canada] ; Rada Boskovic [Canada] ; Stephen J. Kish [Canada] ; Alan A. Wilson [Canada] ; Sylvain Houle [Canada] ; Jeffrey H. Meyer [Canada]	Dynamic, adaptive changes in MAO-A binding after alterations in substrate availability: an in vivo [11C]-harmine positron emission tomography study
001D22 (2010)	T. Van Eimeren [Canada] ; G. Pellecchia [Canada] ; R. Cilia [Canada] ; B. Ballanger [Canada] ; T. D. L. Steeves [Canada] ; S. Houle [Canada] ; J. M. Miyasaki [Canada] ; M. Zurowski [Canada] ; A. E. Lang [Canada] ; A. P. Strafella [Canada]	Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD
001E54 (2009)	Abdoul Kane [Canada] ; William D. Hutchison ; Mojgan Hodaie ; Andres M. Lozano ; Jonathan O. Dostrovsky	Dopamine-dependent high-frequency oscillatory activity in thalamus and subthalamic nucleus of patients with Parkinson's disease.
001E57 (2009)	Thilo Van Eimeren [Canada] ; Bénédicte Ballanger [Canada] ; Giovanna Pellecchia [Canada] ; Janis M. Miyasaki [Canada] ; Anthony E. Lang [Canada] ; Antonio P. Strafella [Canada]	Dopamine Agonists Diminish Value Sensitivity of the Orbitofrontal Cortex: A Trigger for Pathological Gambling in Parkinson’s Disease?
002904 (2006)	Evelyn F. Field [Canada] ; Gerlinde A. Metz [Canada] ; Sergio M. Pellis [Canada] ; Ian Q. Whishaw [Canada]	Sexually dimorphic postural adjustments during vertical behaviour are altered in a unilateral 6-OHDA rat model of Parkinson's disease
002915 (2006)	Rohita Sharma [Canada] ; Catherine R. Mcmillan [Canada] ; Catherine C. Tenn [Canada] ; Lennard P. Niles [Canada]	Physiological neuroprotection by melatonin in a 6-hydroxydopamine model of Parkinson's disease
002952 (2005)	Kelly K. Meissner [Canada] ; David L. Kirkham ; Laurie C. Doering	Transplants of neurosphere cell suspensions from aged mice are functional in the mouse model of Parkinson's.
002999 (2005)	Philip Seeman [Canada] ; Françoise Ko ; Matth Us Willeit ; Patrick Mccormick ; Nathalie Ginovart	Antiparkinson concentrations of pramipexole and PHNO occupy dopamine D2(high) and D3(high) receptors.
002A20 (2005)	Gerlinde A. Metz [Canada] ; Arthur Tse ; Mark Ballermann [Canada] ; Lori K. Smith [Canada] ; Karim Fouad [Canada]	The unilateral 6‐OHDA rat model of Parkinson's disease revisited: an electromyographic and behavioural analysis
002F15 (2003)	Pershia Samadi [Canada] ; Laurent Gregoire [Canada] ; Paul J. Bedard [Canada]	Opioid antagonists increase the dyskinetic response to dopaminergic agents in parkinsonian monkeys: interaction between dopamine and opioid systems
002F55 (2002)	J F Gagnon [Canada] ; J. Montplaisir ; M A Bédard	[Rapid-eye-movement sleep disorders in Parkinson's disease].
003363 (2000)		Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.
003545 (2000)	Frédéric Calon ; Marc Morissette ; Martin Goulet ; Richard Grondin ; Pierre J. Blanchet ; Paul J. Bédard ; Thérèse Di Paolo	125I-CGP 64213 Binding to GABAB Receptors in the Brain of Monkeys: Effect of MPTP and Dopaminomimetic Treatments
003867 (1998)	M. Morissette ; M. Goulet ; R. Grondin ; P. Blanchet ; P J Bédard ; T. Di Paolo ; D. Lévesque	Associative and limbic regions of monkey striatum express high levels of dopamine D3 receptors: effects of MPTP and dopamine agonist replacement therapies.
003A98 (1997)	Marc Morissette [Canada] ; Martin Goulet [Canada] ; Jean-Jacques Soghomonian [Canada] ; Pierre J. Blanchet [Canada] ; Frédéric Calon [Canada] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada]	Preproenkephalin mRNA expression in the caudate-putamen of MPTP monkeys after chronic treatment with the D2 agonist U91356A in continuous or intermittent mode of administration: comparison with l-DOPA therapy
003C96 (1996)	J P Doucet [Canada] ; Y. Nakabeppu ; P J Bedard ; B T Hope ; E J Nestler ; B J Jasmin ; J S Chen ; M J Iadarola ; M. St-Jean ; N. Wigle ; P. Blanchet ; R. Grondin ; G S Robertson	Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of deltaFosB-like protein(s) in both the rodent and primate striatum.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Dopamine Agonists (pharmacology)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Dopamine Agonists (pharmacology)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Dopamine Agonists (pharmacology)
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022